A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma	Metastatic Pancreatic Adenocarcinoma	Active, not recruiting	Phase 1 / Phase 2	2025-12-19		NCT05249101

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CG Pharmaceuticals, Inc	1

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Barbara Ann Karmanos Cancer Institute	Detroit	United States	44
Clinical Research Alliance	Westbury	United States	14
Community Health Network	Indianapolis	United States	16
Hoag Medical Group	Newport Beach	United States	1
HonorHealth Research Institute	Scottsdale	United States	36
Norton Cancer Institute Audubon	Louisville	United States	1
Penn State Hershey Cancer Institute	Hershey	United States	4
Roswell Park Comprehensive Cancer Center	Buffalo	United States	63
The University of Texas MD Anderson Cancer Center	Houston	United States	207
The University of Texas Southwestern Medical Center	Dallas	United States	37
UCLA Hematology/Oncology, Gastrointestinal Oncology	Santa Monica	United States	1
UCSF Medical Center	San Francisco	United States	26
University Cancer and Blood Center	Athens	United States	3
University Medical Center New Orleans	New Orleans	United States	142
Utah Cancer Specialists	Salt Lake City	United States	2
Virginia Cancer Specialists	Fairfax	United States	109